Transforming growth factor-β induces fibrosis in immune cell-depleted lungs

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 285, Issue 3 29-3, 2003, Pages

  Olman, Mitchell A ^a,b,d   Matthay, Michael A ^c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CELL INTERACTION; CELL MIGRATION; DENDRITIC CELL; EDITORIAL; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; IMMUNE DEFICIENCY; LUNG FIBROSIS; LUNG SLICE; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0042510790     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00110.2003     Document Type: Editorial

References (39)

1. Adamson IY, Hedgecock C, and Bowden DH. Epithelial cell-fibroblast interactions in lung injury and repair. Am J Pathol 137: 385-392, 1990.
2. Adamson IY, Young L, and Bakowska J. Enhanced alveolar type II cell growth on a pulmonary extracellular matrix over fibroblasts. Am J Physiol Lung Cell Mol Physiol 272: L413-L417, 1997.
3. Bensadoun ES, Burke AK, Hogg JC, and Roberts CR. Proteoglycan deposition in pulmonary fibrosis. Am J Respir Crit Care Med 154: 1819-1828, 1996.
4. Blobe GC, Schiemann WP, and Lodish HF. Role of transforming growth factor β in human disease. N Engl J Med 342: 1350-1358, 2000.
5. Bonner JC and Brody AR. Cytokine-binding proteins in the lung. Am J Physiol Lung Cell Mol Physiol 268: L869-L878, 1995.
6. Broekelmann TJ, Limper AH, Colby TV, and McDonald JA. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 88: 6642-6646, 1991.
7. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, and Boivin GP. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93: 1159-1170, 1998.
8. Dunsmore SE, Roes J, Chua FJ, Segal AW, Mutsaers SE, and Laurent GJ. Evidence that neutrophil elastase-deficient mice are resistant to bleomycin-induced fibrosis. Chest 120: 35S-36S, 2001.
9. Giri SN, Hyde DM, Braun RK, Gaarde W, and Harper JR. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol 54: 1205-1216, 1997.
10. Giri SN, Hyde DM, and Hollinger MA. Effect of antibody to transforming growth factor β on bleomycin induced accumulation of lung collagen in mice. Thorax 48: 959-966, 1993.
11. Holgate ST, Davies DE, Lackie PM, Wilson SJ, Puddicombe SM, and Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 105: 193-204, 2000.
12. Khalil N, Corne S, Whitman C, and Yacyshyn H. Plasmin regulates the activation of cell-associated latent TGF-β1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol 15: 252-259, 1996.
13. Khalil N, Parekh TV, O'Connor R, Antman N, Kepron W, Yehaulaeshet T, Xu YD, and Gold LI. Regulation of the effects of TGF-β1 by activation of latent TGF-β1 and differential expression of TGF-β receptors (TβR-I and TβR-II) in idiopathic pulmonary fibrosis. Thorax 56: 907-915, 2001.
14. Klien JH and Adamson IY. Fibroblast inhibition and prostaglandin secretion by alveolar epithelial cells exposed to silica. Lab Invest 60: 808-813, 1989.
15. Kolb M, Margetts PJ, Galt T, Sime PJ, Xing Z, Schmidt M, and Gauldie J. Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am J Respir Crit Care Med 163: 770-777, 2001.
16. Lee CG, Homer RJ, Koteliansky VE, Lanone S, Wang X, Koteliansky VE, Shipley JM, Gotwals P, Noble P, Chen Q, Senior RM, and Elias JA. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1. J Exp Med 194: 809-821, 2001.
17. Letterio JJ and Roberts AB. Regulation of immune responses by TGF-β. Annu Rev Immunol 16: 137-161, 1998.
18. Liu JY, Sime PJ, Wu T, Warshamana GS, Pociask D, Tsai SY, and Brody AR. Transforming growth factor-β1 overexpression in tumor necrosis factor-α receptor knockout mice induces fibroproliferative lung disease. Am J Respir Cell Mol Biol 25: 3-7, 2001.
19. 2. Am J Physiol Lung Cell Mol Physiol 284: L342-L349, 2003.
20. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, Rifkin DB, and Sheppard D. The integrin αvβ6 binds and activates latent TGF β1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328, 1999.
21. Murphy-Ullrich JE, Schultz-Cherry S, and Hook M. Transforming growth factor-β complexes with thrombospondin. Mol Biol Cell 3: 181-188, 1992.
22. Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Miyazono K, and Iwamoto I. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 104: 5-11, 1999.
23. Olman M. Epithelial cell modulation of airway fibrosis in asthma. Am J Respir Cell Mol Biol 28: 125-128, 2003.
24. Olman M, Mackman N, Gladson C, Moser K, and Loskutoff D. Changes in procoagulant and fibrinolytic gene expression during bleomycin induced lung injury in the mouse. J Clin Invest 96: 1621-1630, 1995.
25. Pittet JF, Griffiths MJD, Geiser T, Kaminski N, Dalton SL, Huang X, Brown LAS, Gotwals PJ, Koteliansky VE, Matthay MA, and Sheppard D. TGF-β is a critical mediator of acute lung injury. J Clin Invest 107: 1537-1544, 2001.
26. Pugin J, Verghese GM, Widmer MC, and Matthay MA. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 27: 304-312, 1999.
27. Ray P, Tang W, Wang P, Homer R, Kuhn C, Flavell RA, and Elias JA. Regulated overexpression of interleukin 11 in the lung: use to dissociate development-dependent and -independent phenotypes. J Clin Invest 100: 2501-2511, 1997.
28. Sime PJ, Xing Z, Graham FL, Csaky KG, and Gauldie J. Adenovector-mediated gene transfer of active transforming growth factor-β1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100: 768-776, 1997.
29. Taipale J, Miyazono K, Heldin CH, and Keski-Oja J, Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol 124: 171-181, 1994.
30. Ware LB and Matthay MA. Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol 282: L924-L940, 2002.
31. Xu YD, Hua J, Mui A, O'Connor R, Grotendorst G, and Khalil N. Release of biologically active TGF-β1 by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 285: L527-L539, 2003.
32. Yehualaeshet T, O'Connor R, Begleiter A, Murphy-Ullrich JE, Silverstein R, and Khalil N. A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat. Am J Respir Cell Mol Biol 23: 204-212, 2000.
33. Yehualaeshet T, O'Connor R, Green-Johnson J, Mai S, Silverstein R, Murphy-Ullrich JE, and Khalil N. Activation of rat alveolar macrophage-derived latent transforming growth factor β-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor. Am J Pathol 155: 841-851, 1999.
34. Young L and Adamson IY. Epithelial-fibroblast interactions in bleomycin-induced lung injury and repair. Environ Health Perspect 101: 56-61, 1993.
35. Yue J and Mulder KM. Transforming growth factor-β signal transduction in epithelial cells. Pharmacol Ther 91: 1-34, 2001.
36. Zhao MQ, Amir MK, Rice WR, and Enelow RI. Type II pneumocyte-CD8+ T-cell interactions. Relationship between target cell cytotoxicity and activation. Am J Respir Cell Mol Biol 25: 362-369, 2001.
37. Zhu HJ and Burgess AW. Regulation of transforming growth factor-β signaling. Mol Cell Biol 4: 321-330, 2001.
38. Ziesche R, Hofbauer E, Wittmann K, Petkov V, and Block LH. A preliminary study of long-term treatment with interferon γ-1β and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 341: 1264-1269, 1999.
39. Zimmerman CM and Padgett RW. Transforming growth factor β signaling mediators and modulators. Gene 249: 17-30, 2000.